Phase 2 eosinophilic esophagitis Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
A Study in Adult Participants With EoE to Evaluate Vonoprazan 20 mg Compared to Placebo After 12 Weeks and to Evaluate Vonoprazan 20 mg Up to 24 Weeks
eosinophilic esophagitis
Phathom Pharmaceuticals, Inc.80 enrolled41 locationsNCT06851559
Recruiting
Phase 1Phase 2
A Trial to Evaluate EP-104GI in Adults With Eosinophilic Esophagitis (EoE).
eosinophilic esophagitis
Eupraxia Pharmaceuticals Inc.117 enrolled23 locationsNCT05608681
Recruiting
Phase 2
Zemaira Eosinophilic Esophagitis Pilot Study
eosinophilic esophagitis
Children's Hospital Medical Center, Cincinnati15 enrolled2 locationsNCT05485155
Recruiting
Phase 2
Dupilumab Versus Topical Corticosteroid Effectiveness - Comparison in the Treatment of Stenotic EoE
eosinophilic esophagitis
University of Colorado, Denver72 enrolled1 locationNCT06705387